干扰素联合利巴韦林对重症冠状病毒感染患者死亡风险的影响:基于既往MERS-CoV研究的系统评价
洪东升, 王融溶, 叶子奇, 饶跃峰, 徐凯进, 卢晓阳
The effect of interferon combined with ribavirin on the risk of death in patients with severe coronavirus Infection: A systematic review based on previous MERS-CoV studies
HONG Dong-sheng, WANG Rong-rong, YE Zi-qi, RAO Yue-feng, XU Kai-jin, LU Xiao-yang
中国医院药学杂志
.
2020, (9): 960
-963,967
.
DOI: 10.13286/j.1001-5213.2020.09.02
